Schizophrenia Spectrum and Psychotic Disorders

Patients, Psychiatrists Frustrated With Existing Schizophrenia Meds

In survey, patients with schizophrenia and psychiatrists both expressed displeasure over efficacy and side effects of current antipsychotics.

Results from a recent survey of adults with schizophrenia, caregivers of adults with schizophrenia and psychiatrists imply that surveyed groups may feel frustrated by the tradeoffs being made with current schizophrenia treatment options and may be seeking greater balance in medications— ones that can address the symptoms of schizophrenia, while also reducing side effects.

The Living with Schizophrenia survey was conducted by Harris Poll on behalf of Otsuka America Pharmaceutical, Inc. and Lundbeck between March 26 and April 8, 2015, among 120 U.S. adults ages 18+ who have been diagnosed with schizophrenia; 300 U.S. adults ages 18+ who provide unpaid care to an adult with schizophrenia (“caregivers”) and 151 U.S. psychiatrists who treat adults 18+ with schizophrenia. Subjects were invited by email to participate and adults with schizophrenia were not required to currently be on medication for their schizophrenia symptoms.

READ FULL ARTICLE Curated publisher From Benzinga